Upgrade to SI Premium - Free Trial

Amgen (AMGN) stock soars on positive obesity drug update, analyst raises PT

May 3, 2024 5:48 AM
On Thursday, Amgen (NASDAQ: AMGN) is discontinuing its experimental weight loss pill, choosing instead to focus on its injectable drug ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change Hot List Momentum Movers

Next Articles